SEQITOPE Trademark

Trademark Overview


On Friday, July 11, 2025, a trademark application was filed for SEQITOPE with the United States Patent and Trademark Office. The USPTO has given the SEQITOPE trademark a serial number of 79431868. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 4, 2025. This trademark is owned by AAX Biotech AB. The SEQITOPE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research, development, engineering, laboratory, and testing services; research, development, engineering, testing, consulting, and analytical services for analysing and quantifying the diversity of the immune system; research, development, engineering, testing, consulting, and analytical services for discovering immune targets; research, engineering, testing, consulting, and analytical services for epitope mapping; providing sequencing data and analysis of the immune system for vaccine development and vaccine optimisation; research and development of antibodies, therapeutics, vaccines, immunotherapies, and diagnostics; research services in the field of immune repertoire analysis, personalised medicine, vaccines, immunotherapies, and diagnostics and related consultation services; providing computational analysis of the immune repertoire; research, development, engineering, testing, consulting, laboratory, and analytical services in the field of drug discovery and drug screeni...
seqitope

General Information


Serial Number79431868
Word MarkSEQITOPE
Filing DateFriday, July 11, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, September 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesScientific research, development, engineering, laboratory, and testing services; research, development, engineering, testing, consulting, and analytical services for analysing and quantifying the diversity of the immune system; research, development, engineering, testing, consulting, and analytical services for discovering immune targets; research, engineering, testing, consulting, and analytical services for epitope mapping; providing sequencing data and analysis of the immune system for vaccine development and vaccine optimisation; research and development of antibodies, therapeutics, vaccines, immunotherapies, and diagnostics; research services in the field of immune repertoire analysis, personalised medicine, vaccines, immunotherapies, and diagnostics and related consultation services; providing computational analysis of the immune repertoire; research, development, engineering, testing, consulting, laboratory, and analytical services in the field of drug discovery and drug screening; scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 4, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAAX Biotech AB
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressSE

Trademark Events


Event DateEvent Description
Thursday, September 4, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, September 8, 2025APPLICATION FILING RECEIPT MAILED
Monday, September 8, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED